$2.48T
Total marketcap
$77.74B
Total volume
BTC 51.95%     ETH 14.30%
Dominance

Vistin Pharma ASA VP4.F Stock

1.9 EUR {{ price }} 1.066666% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
85.47M EUR
LOW - HIGH [24H]
1.9 - 1.9 EUR
VOLUME [24H]
1K EUR
{{ volume }}
P/E Ratio
17.22
Earnings per share
0.11 EUR

Vistin Pharma ASA Price Chart

Vistin Pharma ASA VP4.F Financial and Trading Overview

Vistin Pharma ASA stock price 1.9 EUR
Previous Close 2.07 EUR
Open 2.07 EUR
Bid 2.06 EUR x N/A
Ask 2.1 EUR x N/A
Day's Range 2.07 - 2.07 EUR
52 Week Range 1.08 - 2.1 EUR
Volume 1.53K EUR
Avg. Volume 36 EUR
Market Cap 92.02M EUR
Beta (5Y Monthly) 1.074712
PE Ratio (TTM) 207
EPS (TTM) 0.11 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date May 21, 2021
1y Target Est N/A

VP4.F Valuation Measures

Enterprise Value 108.72M EUR
Trailing P/E 207
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.24699624
Price/Book (mrq) 0.33962265
Enterprise Value/Revenue 0.292
Enterprise Value/EBITDA 2.886

Trading Information

Vistin Pharma ASA Stock Price History

Beta (5Y Monthly) 1.074712
52-Week Change 29.23%
S&P500 52-Week Change 20.43%
52 Week High 2.1 EUR
52 Week Low 1.08 EUR
50-Day Moving Average 1.82 EUR
200-Day Moving Average 1.54 EUR

VP4.F Share Statistics

Avg. Volume (3 month) 36 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 44.34M
Float 18.85M
Short Ratio N/A
% Held by Insiders 55.14%
% Held by Institutions 12.08%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.75
Trailing Annual Dividend Yield 36.23%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 2.00%
Operating Margin (ttm) 6.65%
Gross Margin 55.60%
EBITDA Margin 10.10%

Management Effectiveness

Return on Assets (ttm) 4.40%
Return on Equity (ttm) 2.80%

Income Statement

Revenue (ttm) 372.57M EUR
Revenue Per Share (ttm) 8.4 EUR
Quarterly Revenue Growth (yoy) 203.90%
Gross Profit (ttm) 166.79M EUR
EBITDA 37.67M EUR
Net Income Avi to Common (ttm) 7.46M EUR
Diluted EPS (ttm) 0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.06M EUR
Total Cash Per Share (mrq) 0.07 EUR
Total Debt (mrq) 27.08M EUR
Total Debt/Equity (mrq) 10.02 EUR
Current Ratio (mrq) 1.401
Book Value Per Share (mrq) 6.095

Cash Flow Statement

Operating Cash Flow (ttm) 17.05M EUR
Levered Free Cash Flow (ttm) -33130750 EUR

Profile of Vistin Pharma ASA

Country Germany
State N/A
City Oslo
Address OestensjOeveien 27
ZIP 0661
Phone 47 35 98 42 00
Website https://www.vistin.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 77

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Q&A For Vistin Pharma ASA Stock

What is a current VP4.F stock price?

Vistin Pharma ASA VP4.F stock price today per share is 1.9 EUR.

How to purchase Vistin Pharma ASA stock?

You can buy VP4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vistin Pharma ASA?

The stock symbol or ticker of Vistin Pharma ASA is VP4.F.

Which industry does the Vistin Pharma ASA company belong to?

The Vistin Pharma ASA industry is Drug Manufacturers-Specialty & Generic.

How many shares does Vistin Pharma ASA have in circulation?

The max supply of Vistin Pharma ASA shares is 45.1M.

What is Vistin Pharma ASA Price to Earnings Ratio (PE Ratio)?

Vistin Pharma ASA PE Ratio is 17.22727200 now.

What was Vistin Pharma ASA earnings per share over the trailing 12 months (TTM)?

Vistin Pharma ASA EPS is 0.11 EUR over the trailing 12 months.

Which sector does the Vistin Pharma ASA company belong to?

The Vistin Pharma ASA sector is Healthcare.